Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial

BACKGROUND: Allogeneic stem cell transplantation is usually considered the only curative treatment option for patients with advanced or transformed myelodysplastic syndromes in complete remission, but post-remission chemotherapy and autologous stem cell transplantation are potential alternatives, es...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: de Witte, Theo, Hagemeijer, Anne, Suciu, Stefan, Belhabri, Amin, Delforge, Michel, Kobbe, Guido, Selleslag, Dominik, Schouten, Harry C., Ferrant, Augustin, Biersack, Harald, Amadori, Sergio, Muus, Petra, Jansen, Joop H., Hellström-Lindberg, Eva, Kovacsovics, Tibor, Wijermans, Pierre, Ossenkoppele, Gert, Gratwohl, Alois, Marie, Jean-Pierre, Willemze, Roel
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Ferrata Storti Foundation 2010
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2948102/
https://ncbi.nlm.nih.gov/pubmed/20494931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2009.019182
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia